118 related articles for article (PubMed ID: 36935086)
1. Expression and functional activity of myosin II in hyperplastic prostates of varying volumes.
Liu J; Liu D; Zhang J; He W; Guo Y; Li Y; Chen P; DiSanto ME; Zhang X
Cell Signal; 2023 Jun; 106():110658. PubMed ID: 36935086
[TBL] [Abstract][Full Text] [Related]
2. Changes in the expression and functional activities of Myosin II isoforms in human hyperplastic prostate.
He W; Wang X; Zhan D; Li M; Wang Q; Liu J; Liu D; Fu X; Qian Q; Li Y; Chen P; Zeng G; Wang X; DiSanto ME; Zhang X
Clin Sci (Lond); 2021 Jan; 135(1):167-183. PubMed ID: 33393635
[TBL] [Abstract][Full Text] [Related]
3. The expression and functional activities of smooth muscle myosin and non-muscle myosin isoforms in rat prostate.
Chen P; Yin J; Guo YM; Xiao H; Wang XH; DiSanto ME; Zhang XH
J Cell Mol Med; 2018 Jan; 22(1):576-588. PubMed ID: 28990332
[TBL] [Abstract][Full Text] [Related]
4. Testosterone regulates myosin II isoforms expression and functional activity in the rat prostate.
Chen P; Xiao H; Huang W; Xu DQ; Guo YM; Wang X; Wang XH; DiSanto ME; Zhang XH
Prostate; 2018 Dec; 78(16):1283-1298. PubMed ID: 30073674
[TBL] [Abstract][Full Text] [Related]
5. Alteration of the Expression and Functional Activities of Myosin II Isoforms in Enlarged Hyperplastic Prostates.
Wang X; He W; Chen H; Yang R; Su H; DiSanto ME; Zhang X
J Pers Med; 2024 Apr; 14(4):. PubMed ID: 38673008
[TBL] [Abstract][Full Text] [Related]
6. Blebbistatin modulates prostatic cell growth and contrapctility through myosin II signaling.
Chen P; Xu DQ; Xu SL; Xiao H; Wan SH; Wang XH; DiSanto ME; Zhang XH
Clin Sci (Lond); 2018 Oct; 132(20):2189-2205. PubMed ID: 30279228
[TBL] [Abstract][Full Text] [Related]
7. Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue.
Lin VK; Wang D; Lee IL; Vasquez D; Fagelson JE; McConnell JD
Prostate; 2000 Aug; 44(3):193-203. PubMed ID: 10906735
[TBL] [Abstract][Full Text] [Related]
8. Blebbistain, a myosin II inhibitor, as a novel strategy to regulate detrusor contractility in a rat model of partial bladder outlet obstruction.
Zhang X; Seftel A; DiSanto ME
PLoS One; 2011; 6(10):e25958. PubMed ID: 22016792
[TBL] [Abstract][Full Text] [Related]
9. Ghrelin Aggravates Prostate Enlargement in Rats with Testosterone-Induced Benign Prostatic Hyperplasia, Stromal Cell Proliferation, and Smooth Muscle Contraction in Human Prostate Tissues.
Wang X; Wang Y; Gratzke C; Sterr C; Yu Q; Li B; Strittmatter F; Herlemann A; Tamalunas A; Rutz B; Ciotkowska A; Waidelich R; Liu C; Stief CG; Hennenberg M
Oxid Med Cell Longev; 2019; 2019():4748312. PubMed ID: 31885795
[TBL] [Abstract][Full Text] [Related]
10. Smooth muscle myosin expression, isoform composition, and functional activities in rat corpus cavernosum altered by the streptozotocin-induced type 1 diabetes.
Zhang X; Kanika ND; Melman A; DiSanto ME
Am J Physiol Endocrinol Metab; 2012 Jan; 302(1):E32-42. PubMed ID: 21917637
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of Oxytocin Receptor in the Hyperplastic Prostate.
Li Z; Xiao H; Wang K; Zheng Y; Chen P; Wang X; DiSanto ME; Zhang X
Front Endocrinol (Lausanne); 2018; 9():403. PubMed ID: 30123183
[No Abstract] [Full Text] [Related]
12. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
[TBL] [Abstract][Full Text] [Related]
13. Testosterone regulates smooth muscle contractile pathways in the rat prostate: emphasis on PDE5 signaling.
Zhang X; Zang N; Wei Y; Yin J; Teng R; Seftel A; Disanto ME
Am J Physiol Endocrinol Metab; 2012 Jan; 302(2):E243-53. PubMed ID: 22028410
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway.
Wang Z; Yang S; Li Y; Zhou Y; Liu D; Liu J; DiSanto ME; Zhang X
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902342
[TBL] [Abstract][Full Text] [Related]
15. Changes in the expression and function of the PDE5 pathway in the obstructed urinary bladder.
He W; Xiang H; Liu D; Liu J; Li M; Wang Q; Qian Q; Li Y; Fu X; Chen P; Guo Y; Zeng G; Wu Z; Zhan D; Wang X; DiSanto ME; Zhang X
J Cell Mol Med; 2020 Nov; 24(22):13181-13195. PubMed ID: 33009887
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
[TBL] [Abstract][Full Text] [Related]
17. Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial-mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway.
Liu D; Liu J; Li Y; Liu H; Hassan HM; He W; Li M; Zhou Y; Fu X; Zhan J; Wang Z; Yang S; Chen P; Xu D; Wang X; DiSanto ME; Zeng G; Zhang X
Prostate; 2021 Dec; 81(16):1435-1449. PubMed ID: 34553788
[TBL] [Abstract][Full Text] [Related]
18. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
[TBL] [Abstract][Full Text] [Related]
19. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
Jin R; Strand DW; Forbes CM; Case T; Cates JMM; Liu Q; Ramirez-Solano M; Milne GL; Sanchez S; Wang ZY; Bjorling DE; Miller NL; Matusik RJ
Prostate; 2021 Sep; 81(13):944-955. PubMed ID: 34288015
[TBL] [Abstract][Full Text] [Related]
20. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume.
Xia BW; Zhao SC; Chen ZP; Chen C; Liu TS; Yang F; Yan Y
Prostate; 2020 May; 80(6):481-490. PubMed ID: 32104919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
